Search Press releases

Press releases teaser image
17 Apr 2026

Acquisition of own shares

Read More
Press releases teaser image
17 Apr 2026

UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

Read More
Press releases teaser image
15 Apr 2026

UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting

Read More
Press releases teaser image
10 Apr 2026

Acquisition of own shares

Read More
Press releases teaser image
3 Apr 2026

Acquisition of own shares

Read More
Press releases teaser image
31 Mar 2026

European Commission approves KYGEVVI[®]▼ (doxecitine and doxribtimine) as first and only treatment for Thymidine Kinase 2 Deficiency (TK2d)

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe